History Taking Zinc code: UKACL1878ea Date of preparation May 2015 AstraZeneca provided funding & reviewed for technical accuracy.

Slides:



Advertisements
Similar presentations
Definition of COPD COPD is a preventable and treatable disease with some significant extrapulmonary effects that may contribute to the severity in individual.
Advertisements

GOLD MANAGEMENT PLAN FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
or more simply.. -asthma is a condition of paroxysmal reversible airway obstruction which is characterised by : Airflow limitation ( reversible) Airway.
2012 UPDATE. What guidelines do we have available to follow for asthma 1) Asthma GP monitoring Guideline 2) Asthma Diagnosis Guideline 3) Acute asthma.
Academy Board Prep PCCM
Improving Inhaler Technique through Community Pharmacy Service Greater Manchester Area Team January 2015.
Obstructive Airways Disease Asthma and COPD Dr H Ahmad VTS 29/04/2009.
Applied Epidemiology Epidemiology of Chronic Obstructive Pulmonary Disease (COPD) By Chris Callan 23 April 2008.
By: E. Salehifar Clinical Pharmacist
Asthma Diagnosis Prescribing Acute Management Tracey Bradshaw Respiratory Consultant RIE.
Chronic Obstructive Pulmonary Disease Natasha Chowdhury.
COPD MANAGEMENT FALLS SHORT AT RCRMC Jean Solomon, M.D.
Definition of COPD COPD is a preventable and treatable disease with some significant extrapulmonary effects that may contribute to the severity in individual.
Chronic obstructive pulmonary disease (COPD) Professor Bill MacNee
COPD GUIDELINES Sarah Cowdell. WHY GUIDELINES MATTER Predicted to be the third leading cause of death by 2030 Cause of over 30,000 deaths in the UK yearly.
22/06/2011.  Asthma – an introduction (Vanessa)  Diagnosis and management of chronic asthma in line with current BTS guidelines (Dr Lowery)  3 x Case.
COPD Management of Stable COPD Shyam Rao May 2014.
1 British Guideline on the Management of Asthma BTS/SIGN British Guideline on the Management of Asthma, May 2008 Introduction Diagnosis Non-pharmacological.
British Guideline on the Management of Asthma. Aims Review of current SIGN/BTS guidelines –Diagnosing Asthma –Stepwise management of Asthma –Managing.
Obstructive Airways Disease Asthma and COPD. Definitions: Asthma: It's a chronic respiratory condition that causes the airways to constrict become inflamed.
Practice Support Program in COPD: South Okanagan Project COPD CARE Algorithm South Okanagan, Interior Health Patricia Rattee RRT, CRE Shannon Walker MD,
Approach to bronchiectasis
Asthma Management Fine Tuning  Maximum control with minimum medication  Start with mild asthma and work up the scale (BTS/SIGN 2004)
Chronic Obstructive Pulmonary Disease. Why COPD is Important ? COPD is the only chronic disease that is showing progressive upward trend in both mortality.
Habib GHEDIRA, MD, Prof. Medical Faculty of Tunis
Interpretation Normal Spirometry Obstructive pattern Restrictive pattern Mixed pattern Small airway obstruction Non-specific ventilatory pattern Probably.
Matt Wong + Sheila Murphy Dec 13 th  AKT MINI EXAM  NICE – COPD GUIDELINES  BTS ASTHMA GUIDELINES  INHALER TECHNIQUE  QOF  SPIROMETRY  CSA.
© 2013 Global Initiative for Chronic Obstructive Lung Disease
Bronchial Asthma  Definition  Patho-physiology  Diagnosis  Management.
Respiratory COPD/Asthma.
يکشنبه، 2015/10/11يکشنبه، 2015/10/11يکشنبه، 2015/10/11يکشنبه، 2015/10/11يکشنبه، 2015/10/11يکشنبه، 2015/10/11 بسم الله الرحمن الرحیم با سلام.
Assessing Risk (Future) Domain – Of adverse events in the future, especially of exacerbations and of progressive, irreversible loss of pulmonary function—is.
Definition COPD def- A disease state characterized by air flow limitation that is not fully reversible It is expected to be the 3 rd leading cause of.
Normal and abnormal Prof. J. Hanacek, MD, PhD
GOLD Update 2011 Rabab A. El Wahsh, MD. Lecturer of Chest Diseases and Tuberculosis Minoufiya University REVISED 2011.
Component 1: Measures of Assessment and Monitoring n Two aspects: –Initial assessment and diagnosis of asthma –Periodic assessment and monitoring.
COPD Diagnosis & Management Anil Ramineni Specialist Respiratory Physiotherapist Community Respiratory Team.
Component 4 Medications. Key Points - Medications  2 general classes: – Long-term control medications – Quick-Relief medications  Controller medications:
Maggie Harris Independent Respiratory Nurse Specialist
ASTHMA MANAGEMENT AND PREVENTION PREFACE Asthma affects an estimated 300 million individuals worldwide. Serious global health problem affecting all age.
Asthma Guidelines, Diagnosis and Management Alison Hughes Respiratory Specialist Nurse Solent NHS Trust.
Wendy Pigg Practice support Pharmacist/Independent Prescriber
Lancet Respir Med 2013; 1: 199–209 R4.신재령 / Prof. 박명재
LSU Journal Club Withdrawal of Inhaled Glucocorticoids and Exacerbations of COPD WISDOM study H. Magnussen MD, et al. Nisha Loganantharaj, PGY1 April 21,
Chronic Obstructive Pulmonary Disease. COPD is an umbrella term for two diseases which cause progressive airflow obstruction Chronic Bronchitis- Inflammation.
Definition Chronic obstructive pulmonary disease (COPD) is characterized by chronic airflow limitation and a range of pathological changes in the lung.
Management of stable chronic obstructive pulmonary disease (2) Seminar Training Primary Care Asthma + COPD D.Anan Esmail.
PICH Childhood Asthma project Bina Chauhan Locum GP 4/5/16.
Clinical Applications of Spirometry for Pediatric Asthma
Effect of primary-care spirometry on the diagnosis and management of COPD P.P. Walker, P. Mitchell, F. Diamantea, C.J. Warburton and L. Davies Eur Respir.
GOLD 2017 major revision: Summary of key changes
Current management of COPD and when to refer?
COPD 2003.
Chronic Obstructive Pulmonary Disease(COPD)
Efficacy and safety of once-daily QVA149 compared with twice-daily salmeterol–fluticasone in patients with chronic obstructive pulmonary disease (ILLUMINATE):
Respiratory disorders
COPD Report 5 Coles Lane, Oakington, Cambridge, CB24 3BA.
Medicines Management – COPD update for LPC Jyoti Saini Hema Patel
Monitoring asthma in primary care
Patterns of asthma medications prescriptions among adult patients in the chest and accident and emergency units of a tertiary health care facility in Uganda.
COPD Dr MAMATHA SARTHI GPST3.
The Role of Fixed-Dose Dual Bronchodilator Therapy in Treating COPD
Volume 153, Issue 4, Pages (April 2018)
Respiratory disorders
20 minute update Asthma and COPD
Gestione clinica della BPCO
Schematic overview of the suggested pharmacological management of chronic obstructive pulmonary disease (COPD). Schematic overview of the suggested pharmacological.
Introduction Project At Crown Street Surgery:
Global Initiative for Chronic Obstructive Lung Disease (GOLD) classification based on symptom and risk evaluation. a) GOLD model of symptom/risk evaluation.
Choosing inhaler therapy for patients with stable COPD based on the Global Initiative for Chronic Obstructive Lung Disease grouping. Choosing inhaler therapy.
Presentation transcript:

History Taking Zinc code: UKACL1878ea Date of preparation May 2015 AstraZeneca provided funding & reviewed for technical accuracy

Natalia

Case study 1 - Natalia Natalia age 53yrs Occupation –manager of a Deli Very light smoking history stopped 30yrs ago Asthma & rhinitis since childhood FH of asthma (mother & brother) Current treatment – Short-acting inhaled beta 2 agonist (SABA) via a metered dose inhaler (MDI) 4-5 times/day

Natalia Previous management of her asthma : Frequent exacerbations Has been nebulised and given oral steroids on many occasions Hospitalised with acute asthma in pregnancy Has been prescribed preventative therapy but didn’t take it regularly- didn’t think it worked Symptoms have become progressively worse over time, little variability

Natalia A full medical & social history was taken Pre & post bronchodilator spirometry was performed by the Practice Nurse Results indicated some reversibility but not to normal, indicating that although Natalia still had asthma she now had some irreversible airways disease due to the chronicity and poor management of her asthma

Natalia Needs both asthma and fixed airways disease treated Commenced on a Long-acting beta 2 agonist (LABA) + Inhaled corticosteroid (ICS) combination product Options?

George

Case study 2- George George is 50yrs old Married Occupation – retired plumber Smoking history - Smoked since he was 16, has reduced from 40 to 25 cigarettes/day quite recently Patient’s Medical History - Nothing of note Current medical history/co-morbidities such as hypertension & hypercholesterolaemia

George The Practice Nurse performs George’s hypertension review In view of George’s significant smoking history and symptoms she arranges for him to come back for spirometry testing In the meantime she suggests that George make an appointment with the GP to arrange referral for a chest Xray

George Post-bronchodilator spirometry has confirmed the diagnosis of moderate airflow obstruction which along with his symptoms confirms a diagnosis of COPD. His COPD assessment test (CAT) score is 15 indicating his symptoms are having a moderate impact on his life Medical Research Council (MRC) score of 1 He needs to have appropriate therapy including smoking cessation

George At the very least George will need a SABA Discuss device options In view of his moderate impairment in lung function and his CAT score indicating disability What other treatment options may he benefit from? Possibly Long-acting Muscarinic Antagonist (LAMA) or LABA? Discuss device options

Bert

Case study 3 - Bert Bert is 64yrs old Retired at 59yrs from the shipyards where he had been a fitter Lives with wife in a 3 rd floor flat Ex-smoker - stopped recently, significant smoking pack history Family History – nothing of note Patient’s Medical History - nothing of note

Case study 3 - Bert Full medical & social history taken –discuss what this should entail Post bronchodilator spirometry indicates basically normal lung function What does this mean? How would you proceed?

Maggie

Case study 4 - Maggie Maggie age 60yrs Retired 4 yrs ago Gave up smoking when she retired as she couldn’t afford them any more Divorced, lives alone Says she was diagnosed with COPD 5yrs ago Attends the surgery for her annual COPD review

Maggie Current history indicates that Maggie is having an acute exacerbation of her COPD What questions would you ask to ascertain this? What features would she present with? What would be your next steps and why?

Maggie Maggie is treated with antibiotics & steroids She is advised to increase her use of SABA to the maximum number of puffs via her spacer Eat little and often Increase her fluid intake Keep warm & stay indoors until she feels better Contact the surgery if there is no improvement in her symptoms

Maggie When she has recovered her post bronchodilator spirometry shows she has severe disease as indicated by a Forced Expiratory Volume in one second (FEV 1 ) 32% predicted She still has a bit of ankle swelling She is currently taking LABA + ICS combination via a DPI and SABA at least 4 times a day, usually more She is still feeling down What would be your next steps & why?

Maggie Maggie needs to be formally assessed for depression and treated accordingly She also needs her treatment optimised Currently she is taking a combination LABA + ICS and a SABA Addition of a LAMA is recommended If sputum is an issue an anti-mucolytic may be useful Non-pharmacological interventions such as referral to pulmonary rehab

Thank you for your attention